Publication | Closed Access

Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial

Breast OncologyOncologyEarly Breast CancerMedicineBreast CancerPharmacotherapyCancer TreatmentPharmacologyGeparsepto—gbg 69Neoadjuvant Chemotherapy